A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer

NCT06709872 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Stage I Ovarian Cancer
Borderline Ovarian Tumors

Sponsor

KU Leuven